Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin), IgG1
Catalog Number:
SYB-CHB263
Product Overview
Article Name:
Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin), IgG1
Biozol Catalog Number:
SYB-CHB263
Supplier Catalog Number:
CHB263
Alternative Catalog Number:
SYB-CHB263-100UG,SYB-CHB263-1MG
Manufacturer:
Sanyou Bio
Category:
Antikörper
Application:
ELISA, FA, FACS, Kinetics
Species Reactivity:
Human
Alternative Names:
RG7599, DNIB0600A
Product Description
Lifastuzumab vedotin is an ADC consisting of a NaPi2b-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer.
Product Properties
Concentration:
1mg/ml
Molecular Weight:
145 kDa
Isotype:
IgG1
NCBI:
95436
UniProt:
O95436
Buffer:
25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Purity:
>90%
Form:
Lyophilize
Target:
NaPi2b / SLC34A2